Using Gentle Music to Ease Anxiety in People Receiving Eye Treatment Injections
NCT ID: NCT07196098
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
144 participants
INTERVENTIONAL
2025-01-10
2025-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Did slow tempo music reduce the anxiety and pain of patients undergoing IVI?
Did the pain threshold differ among patients of different ethnic groups?
Participants were divided into a music intervention group and a control group. Participants in the music group listened to slow tempo music before and during IVI, while participants in the control group received IVI without background music.
The study compared salivary alpha-amylase (sAA) levels-an enzyme that correlates with anxiety level-along with blood pressure (BP) and heart rate (HR) of participants before and after IVI. At the end of the treatment, participants' pain scores were obtained.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Music Therapy on Patients Undergoing Intravitreal Injections
NCT00702039
Effect of Music Therapy on the Anxiety Level of Patients During the Administration of Ocular Intravitreal Injections
NCT05904392
Effect of Music Intervention on Intravitreal Injection
NCT04212338
The Effect of Music on Anxiety in the Appointment Period
NCT06590363
Music Therapy to Reduce Anxiety and Pain in Chronic Pain Patients During Procedures
NCT07252648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible participants were identified among patients scheduled for intravitreal injections (IVI) at the day-care surgery unit of the University of Malaya Medical Centre. Written informed consent was obtained after participants were provided with the participant information sheet and screened based on the study's inclusion and exclusion criteria. A simple random sampling method was used. After consent, each participant was randomly assigned a number using the Random Number Generator from the website https://www.calculatorsoup.com
, which generates numbers without repeats. Odd numbers were allocated to the music intervention group, and even numbers to the control group.
Data collection followed the Data Collection Proforma. Demographic information included age, gender, ethnicity, marital status, comorbid conditions, occupation, and education level. Before entering the operating room (OR), participants' baseline blood pressure (BP₀) and heart rate (HR₀) were recorded.
In this study, a standardised, copyright- and royalty-free piano composition-Andromeda (Piano Solo) by Gabriele Tosi, available for free on YouTube.com-was used. The piece was selected for its consistent tempo of 55-60 beats per minute (BPM) and stable average sound level of 60 decibels (dB). Music was played in the waiting room using a JBL Go3 speaker, with audio transmitted wirelessly via Bluetooth from a Huawei Nova 5T smartphone (Huawei, China). To maintain consistency, the speaker volume was calibrated each morning using the Sound Meter application (Google Play Store), ensuring the sound level remained at approximately 60 dB-comparable to normal conversational volume. Inside the OR, music was played directly from a computer with an attached speaker, and the same calibration method was applied. This volume level was chosen to avoid disrupting the surgeon's focus while allowing clear verbal communication between operating theatre staff and the participant. After listening to music for at least 15 minutes, participants were called into the OR according to their sequence. The same music continued to play in the OR for the music group until the end of the procedure.
Upon entering the OR, baseline samples of salivary alpha-amylase (sAA\_before), BP (BP₁), and HR (HR₁) were measured. Salivary alpha-amylase (sAA) was assessed using the Cocoro Meter (Nipro Inc., Japan). Participants in the control group underwent the same procedure without background music.
All participants, regardless of group allocation, received standard IVI in accordance with clinical practice. The injections were performed under topical anaesthesia using five drops of proparacaine hydrochloride 0.5%, administered at least five minutes before the procedure. The periocular skin was cleaned with 10% povidone-iodine, while the conjunctiva and fornices were irrigated with 5% povidone-iodine and left for three minutes. The eye was then draped, and an eyelid speculum was applied. IVIs were performed under sterile conditions using a 30-gauge needle inserted 3.5-4.0 millimetres from the limbus.
During IVI, additional measurements of BP (BP₂) and HR (HR₂) were taken at the third minute. A second sAA measurement (sAA\_after) was also obtained. Participants' pain levels were assessed using the Visual Analogue Scale for Pain (VAS-P).
Since approximately 30 patients were scheduled for IVI on any given day, their sequence of IVI was categorised for statistical analysis as early (8:00-10:00 a.m.), middle (10:00 a.m.-12:00 p.m.), and late (12:00-2:00 p.m.).
The duration of the procedure, type of anti-vascular endothelial growth factor (anti-VEGF) used, participant sequence, ocular diagnosis, number of prior IVIs, and history of ocular surgery were all documented. Each participant was recruited only once for the study, and no follow-up was required.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
No background music was played before and during intravitreal injections
No interventions assigned to this group
Music Group
Slow tempo music will be played 15 minutes before and during intravitreal injection.
Slow tempo music
Slow tempo music will be played 15 minutes before and during intravitreal injection.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Slow tempo music
Slow tempo music will be played 15 minutes before and during intravitreal injection.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* capable of providing informed consent prior to trial participation.
Exclusion Criteria
* patients with hearing impairment,
* patients with underlying psychological or psychiatric disorder,
* patients with prior salivary gland or facial surgery that could alter saliva secretion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ng Yu Siang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ng Yu Siang
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ng Yu Siang Doctor
Role: PRINCIPAL_INVESTIGATOR
Universiti Malaya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daycare Center, University Malaya Medical Centre
Kuala Lumpur, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sugimoto K, Kanai A, Shoji N. The effectiveness of the Uchida-Kraepelin test for psychological stress: an analysis of plasma and salivary stress substances. Biopsychosoc Med. 2009 Apr 3;3:5. doi: 10.1186/1751-0759-3-5.
Chatterton RT Jr, Vogelsong KM, Lu YC, Ellman AB, Hudgens GA. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clin Physiol. 1996 Jul;16(4):433-48. doi: 10.1111/j.1475-097x.1996.tb00731.x.
Takai N, Yamaguchi M, Aragaki T, Eto K, Uchihashi K, Nishikawa Y. Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adults. Arch Oral Biol. 2004 Dec;49(12):963-8. doi: 10.1016/j.archoralbio.2004.06.007.
Iizuka N, Awano S, Ansai T. Salivary alpha-amylase activity and stress in Japan air self-defense force cargo pilots involved in Iraq reconstruction. Am J Hum Biol. 2012 Jul-Aug;24(4):468-72. doi: 10.1002/ajhb.22247. Epub 2012 Feb 18.
Noto Y, Sato T, Kudo M, Kurata K, Hirota K. The relationship between salivary biomarkers and state-trait anxiety inventory score under mental arithmetic stress: a pilot study. Anesth Analg. 2005 Dec;101(6):1873-1876. doi: 10.1213/01.ANE.0000184196.60838.8D.
Anderson LC, Garrett JR, Johnson DA, Kauffman DL, Keller PJ, Thulin A. Influence of circulating catecholamines on protein secretion into rat parotid saliva during parasympathetic stimulation. J Physiol. 1984 Jul;352:163-71. doi: 10.1113/jphysiol.1984.sp015284.
Skov Olsen P, Kirkegaard P, Rasmussen T, Magid E, Poulsen SS, Nexo E. Adrenergic effects on secretion of amylase from the rat salivary glands. Digestion. 1988;41(1):34-8. doi: 10.1159/000199729.
Batzri S, Selinger Z. Enzyme secretion mediated by the epinephrine -receptor in rat parotid slices. Factors governing efficiency of the process. J Biol Chem. 1973 Jan 10;248(1):356-60. No abstract available.
Bellocchio L, Soria-Gomez E, Quarta C, Metna-Laurent M, Cardinal P, Binder E, Cannich A, Delamarre A, Haring M, Martin-Fontecha M, Vega D, Leste-Lasserre T, Bartsch D, Monory K, Lutz B, Chaouloff F, Pagotto U, Guzman M, Cota D, Marsicano G. Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB(1) receptor blockade. Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4786-91. doi: 10.1073/pnas.1218573110. Epub 2013 Mar 4.
Hız M, Ciğerci Y, Doğan M. The effects of the music intervention on anxiety, pain, vital signs, and patient satisfaction in intravitreal injection: a randomized controlled study. Anatolian Clinic the Journal of Medical Sciences. 2022;27(2):150-61.
Chan JC, Chan LP, Yeung CP, Tang TW, O YM, Lam WC. Effect of Music on Patient Experience during Intravitreal Injection. J Ophthalmol. 2020 Jul 30;2020:9120235. doi: 10.1155/2020/9120235. eCollection 2020.
Brosh K, Roditi E, Wasser LM, Aryan A, Hanhart J, Potter MJ. Effect of Music Selection on Anxiety Level during Intravitreal Injections for Individuals of Varying Cultures. Ophthalmic Epidemiol. 2022 Oct;29(5):582-587. doi: 10.1080/09286586.2021.1955390. Epub 2021 Jul 22.
Chen X, Seth RK, Rao VS, Huang JJ, Adelman RA. Effects of music therapy on intravitreal injections: a randomized clinical trial. J Ocul Pharmacol Ther. 2012 Aug;28(4):414-9. doi: 10.1089/jop.2011.0257. Epub 2012 Apr 16.
Richard-Lalonde M, Gelinas C, Boitor M, Gosselin E, Feeley N, Cossette S, Chlan LL. The Effect of Music on Pain in the Adult Intensive Care Unit: A Systematic Review of Randomized Controlled Trials. J Pain Symptom Manage. 2020 Jun;59(6):1304-1319.e6. doi: 10.1016/j.jpainsymman.2019.12.359. Epub 2019 Dec 24.
Beasley R. Pre-procedural education on anxiety levels during intravitreal injections. International Journal of Ophthalmic Practice. 2011;2(1):20-7.
Jeong K, Kim J, Kim J, Hwang J. Relationship between Pain and Injection Site during Intravitreal Injection. Journal of the Korean Ophthalmological Society. 2016;57:930.
Segal O, Segal-Trivitz Y, Nemet AY, Cohen P, Geffen N, Mimouni M. Anxiety levels and perceived pain intensity during intravitreal injections. Acta Ophthalmol. 2016 Mar;94(2):203-4. doi: 10.1111/aos.12802. Epub 2015 Jul 28. No abstract available.
Rifkin L, Schaal S. Factors affecting patients' pain intensity during in office intravitreal injection procedure. Retina. 2012 Apr;32(4):696-700. doi: 10.1097/IAE.0b013e3182252ad3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
202424-13359
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.